• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDINAL HEALTH SANTA CLARA MYNX CONTROL; DEVICE, HEMOSTASIS, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDINAL HEALTH SANTA CLARA MYNX CONTROL; DEVICE, HEMOSTASIS, VASCULAR Back to Search Results
Catalog Number MX5060E
Device Problems Decrease in Pressure (1490); Material Rupture (1546)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/07/2024
Event Type  malfunction  
Manufacturer Narrative
This device is available for analysis, but the engineering report is not yet available.However, it will be submitted within 30 days upon receipt.Additional information is pending and will be submitted within 30 days upon receipt.
 
Event Description
As reported, the balloon on the 5f mynx control vascular closure device (vcd) burst during prep.Therefore, the product wasn¿t available and manual compression was performed for 20 minutes and recovered.There were no reports of patient injury.The mynx vcd used in a coronary angiogram (cag) procedure.There were no visible signs of device or package damage prior to use.The physician achieved certification on the use of mynx and has used the device several times prior to this procedure.Also, the mynx vcd prepped according to the instructions for use (ifu).A retrograde approach was used.A 5f non-cordis sheath was used.The femoral artery¿s suitability was verified on angiography, including the insertion angle (30-45 degrees) of the vascular sheath introducer.The vessel diameter was verified to be greater than or equal to 5 mm in diameter.There was no vessel tortuosity or presence of pvd / calcium in the vicinity of the puncture site.The device will be returned for evaluation.
 
Manufacturer Narrative
Complaint conclusion: as reported, the balloon on the 5f mynx control vascular closure device (vcd) burst during prep.Therefore, the product wasn¿t available and manual compression was performed for 20 minutes and recovered.There were no reports of patient injury.The mynx vcd was used in a coronary angiogram (cag) procedure.There were no visible signs of device or package damage prior to use.The physician achieved certification on the use of mynx and has used the device several times prior to this procedure.Also, the mynx vcd prepped according to the instructions for use (ifu).A retrograde approach was used.A 5f non-cordis sheath was used.The femoral artery¿s suitability was verified on angiography, including the insertion angle (30-45 degrees) of the vascular sheath introducer.The vessel diameter was verified to be greater than or equal to 5 mm in diameter.There was no vessel tortuosity or presence of peripheral vascular disease (pvd) / calcium in the vicinity of the puncture site.A non-sterile ¿mynx control vcd, 5f (ce mark)¿ involved in the complaint was returned for product investigation.Per visual analysis, the unit was thoroughly inspected observing that both button 1 and button 2 were not depressed.Neither the syringe nor the procedural sheath were returned for analysis.The stopcock was set in the open position, and the sealant remained in its manufactured position.The atraumatic tip did not present any damages or anomalies.No other outstanding details were noticed.Per functional analysis, an inflation/deflation test was performed by injecting water into the returned device according to the ifu.A leaking condition was observed from the balloon.Per microscopic analysis, the balloon was inspected using a vision system to obtain a magnified image, and one pin hole was observed.The reported event of ¿balloon-balloon loss of pressure¿ was confirmed through analysis of the returned device.However, the exact cause of the pin hole condition found could not be conclusively determined during analysis.Based on the limited information available for review and product analysis, it is not possible to determine what factors may have contributed to the issue reported.However, as this issue was found during preparation of the device, handling factors during prep are possible.According to the ifu during the prepare balloon step, which is not intended as a mitigation, ¿fill locking syringe with 2 to 3 ml of sterile saline, attach to stopcock and draw vacuum.Check luer connector and tighten if necessary.Inflate the balloon until the black marker on the inflation indicator is fully visible.Check for leaks in the balloon and syringe connector; retighten if necessary.Discard the device if the balloon does not maintain pressure.Check for air bubbles in the balloon.If air bubbles are visible, deflate the balloon, draw vacuum to remove bubbles and re-inflate.¿ neither the product analysis, nor the information available for review suggest that the reported failure could be related to the design or manufacturing process of the unit.Therefore, no corrective/preventative actions will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYNX CONTROL
Type of Device
DEVICE, HEMOSTASIS, VASCULAR
Manufacturer (Section D)
CARDINAL HEALTH SANTA CLARA
5452 betsy ross drive
santa clara, california 95054
Manufacturer (Section G)
CORDIS US CORP.
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer Contact
karla castro
5452 betsy ross drive
santa clara, california 95054
7863138372
MDR Report Key18918660
MDR Text Key337851343
Report Number3004939290-2024-00120
Device Sequence Number1
Product Code MGB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040044
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 05/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/15/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberMX5060E
Device Lot NumberF2320006
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/29/2024
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received04/23/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/19/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-